Matthew B. Murphy - General Counsel at Nautilus Biotechnology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Stock Symbol
NAUT on Nasdaq
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew B. Murphy since 12/4/2023

Holdings reported by Matthew B. Murphy for Nautilus Biotechnology, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 160K Mar 1, 2024 Direct Common Stock

Transactions reported by Matthew B. Murphy for Nautilus Biotechnology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.